Return On Equity in % of Protara Therapeutics, Inc. from Q2 2015 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Protara Therapeutics, Inc. quarterly/annual Return On Equity history and change rate from Q2 2015 to Q3 2025.
  • Protara Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -35.1 %, a 37.2% increase year-over-year.
  • Protara Therapeutics, Inc. annual Return On Equity for 2024 was -44.7 %, a 10.1% increase from 2023.
  • Protara Therapeutics, Inc. annual Return On Equity for 2023 was -49.7 %, a 1.55% decline from 2022.
  • Protara Therapeutics, Inc. annual Return On Equity for 2022 was -49 %, a 81% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Protara Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -35.1 +20.8 +37.2% 01 Jul 2025 30 Sep 2025
Q2 2025 -36.9 +18.2 +33% 01 Apr 2025 30 Jun 2025
Q1 2025 -36.4 +22.4 +38.1% 01 Jan 2025 31 Mar 2025
Q4 2024 -44.7 +5.04 +10.1% 01 Oct 2024 31 Dec 2024
Q3 2024 -56 +21.1 +27.4% 01 Jul 2024 30 Sep 2024
Q2 2024 -55 +8.58 +13.5% 01 Apr 2024 30 Jun 2024
Q1 2024 -58.8 -5.43 -10.2% 01 Jan 2024 31 Mar 2024
Q4 2023 -49.7 -0.76 -1.55% 01 Oct 2023 31 Dec 2023
Q3 2023 -77.1 -52.2 -210% 01 Jul 2023 30 Sep 2023
Q2 2023 -63.6 -38 -149% 01 Apr 2023 30 Jun 2023
Q1 2023 -53.4 -26.5 -98.6% 01 Jan 2023 31 Mar 2023
Q4 2022 -49 -21.9 -81% 01 Oct 2022 31 Dec 2022
Q3 2022 -24.9 +0.04 +0.16% 01 Jul 2022 30 Sep 2022
Q2 2022 -25.6 -2.95 -13% 01 Apr 2022 30 Jun 2022
Q1 2022 -26.9 -3.56 -15.3% 01 Jan 2022 31 Mar 2022
Q4 2021 -27.1 -0.81 -3.09% 01 Oct 2021 31 Dec 2021
Q3 2021 -24.9 +10.1 +28.8% 01 Jul 2021 30 Sep 2021
Q2 2021 -22.6 +49.5 +68.6% 01 Apr 2021 30 Jun 2021
Q1 2021 -23.3 +77.5 +76.9% 01 Jan 2021 31 Mar 2021
Q4 2020 -26.2 +873 +97.1% 01 Oct 2020 31 Dec 2020
Q3 2020 -35 +372 +91.4% 01 Jul 2020 30 Sep 2020
Q2 2020 -72.2 +73.4 +50.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -101 +9.58 +8.68% 01 Jan 2020 31 Mar 2020
Q4 2019 -899 -801 -819% 01 Oct 2019 31 Dec 2019
Q3 2019 -407 -334 -455% 01 Jul 2019 30 Sep 2019
Q2 2019 -146 -56.4 -63.3% 01 Apr 2019 30 Jun 2019
Q1 2019 -110 -21.7 -24.4% 01 Jan 2019 31 Mar 2019
Q4 2018 -97.8 -10.2 -11.6% 01 Oct 2018 31 Dec 2018
Q3 2018 -73.3 +16.1 +18% 01 Jul 2018 30 Sep 2018
Q2 2018 -89.1 -17.1 -23.8% 01 Apr 2018 30 Jun 2018
Q1 2018 -88.7 -20.5 -30% 01 Jan 2018 31 Mar 2018
Q4 2017 -87.7 -28.1 -47.2% 01 Oct 2017 31 Dec 2017
Q3 2017 -89.4 -37.8 -73.4% 01 Jul 2017 30 Sep 2017
Q2 2017 -72 -28.6 -65.8% 01 Apr 2017 30 Jun 2017
Q1 2017 -68.3 -32.9 -93% 01 Jan 2017 31 Mar 2017
Q4 2016 -59.6 -29.5 -98.1% 01 Oct 2016 31 Dec 2016
Q3 2016 -51.6 -41.3 -401% 01 Jul 2016 30 Sep 2016
Q2 2016 -43.4 -17.7 -68.5% 01 Apr 2016 30 Jun 2016
Q1 2016 -35.4 01 Jan 2016 31 Mar 2016
Q4 2015 -30.1 01 Oct 2015 31 Dec 2015
Q3 2015 -10.3 01 Jul 2015 30 Sep 2015
Q2 2015 -25.8 01 Apr 2015 30 Jun 2015

Protara Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -44.7 +5.04 +10.1% 01 Jan 2024 31 Dec 2024
2023 -49.7 -0.76 -1.55% 01 Jan 2023 31 Dec 2023
2022 -49 -21.9 -81% 01 Jan 2022 31 Dec 2022
2021 -27.1 -0.81 -3.09% 01 Jan 2021 31 Dec 2021
2020 -26.2 +873 +97.1% 01 Jan 2020 31 Dec 2020
2019 -899 -801 -819% 01 Jan 2019 31 Dec 2019
2018 -97.8 -10.2 -11.6% 01 Jan 2018 31 Dec 2018
2017 -87.7 -28.1 -47.2% 01 Jan 2017 31 Dec 2017
2016 -59.6 -29.5 -98.1% 01 Jan 2016 31 Dec 2016
2015 -30.1 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.